Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...
Tecovirimat failed to reduce clade II mpox lesions, pain or viral clearance among participants in a study of the antiviral ...
Experts share here what they take away from CROI each year and why this meeting is so important in this space.
Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.
AllAfrica on MSN12h
'We'll Come to You' - HIV Prevention Project Takes Services to SchoolsElzette Rousseau from the Desmond Tutu HIV Foundation told attendees at the top HIV conference in the United States about a project taking HIV prevention services to schools in Cape Town. Biénne ...
SAN FRANCISCO -- Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence ...
Johnson's group demonstrated in a 2023 study that congenital syphilis is not more likely with a prenatal dose schedule using ...
On March 7, 2025, and again on March 10, scientists, healthcare workers, and more rallied in protest to Trump administration ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
The lack of available medications in the United States for COVID post-exposure prophylaxis leaves household members in close ...
That’s the potential promise of a new study on a drug made by Japanese pharmaceutical company Shionogi. At a scientific ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback